Tag: Immunotherapy

A comprehensive analysis of 136 registered clinical trials reveals that therapeutic vaccines for ovarian cancer have advanced steadily for three ...

New research reveals that inflammatory macrophages fuel metastasis in triple-negative breast cancer by activating a stress-signaling pathway in tumor cells ...

A Cell Research article examines how artificial intelligence-guided engineering of gasdermin pore-forming proteins could be harnessed to selectively eliminate virus-infected ...

A new cost-effectiveness analysis finds nivolumab plus ipilimumab may offer greater quality-adjusted life years at lower cost than pembrolizumab as ...

A comprehensive bibliometric analysis of 979 publications reveals how single-cell RNA sequencing has evolved from cell cataloging to a dynamic, ...

First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...

The 2025 Chinese guidelines consolidate two decades of evidence into an updated roadmap for diagnosing, preventing and treating colorectal cancer ...

A Japanese study found that immune-related adverse events during checkpoint inhibitor therapy for advanced gastric cancer were independently linked to ...

Five-year results from the KEYNOTE-826 trial confirm that adding pembrolizumab to first-line chemotherapy delivers durable survival benefit for patients with ...

The randomized Phase 2 DeLLphi-309 study found that extended-interval tarlatamab dosing every three or four weeks produced efficacy, safety and ...